These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience. Vo AA; Cam V; Toyoda M; Puliyanda DP; Lukovsky M; Bunnapradist S; Peng A; Yang K; Jordan SC Clin J Am Soc Nephrol; 2006 Jul; 1(4):844-52. PubMed ID: 17699296 [TBL] [Abstract][Full Text] [Related]
28. Panel backs pain drug studies with new safety checks. Dolgin E Nat Med; 2012 Apr; 18(4):472. PubMed ID: 22481387 [No Abstract] [Full Text] [Related]
29. Adverse drug reactions in Canada. Hematologic reactions to sterol and sterolin-containing products. Can Fam Physician; 2004 Aug; 50():1115-6. PubMed ID: 15455811 [No Abstract] [Full Text] [Related]
30. [Acute renal failure following treatment with intravenously administered immunoglobulins]. van Zanten AR; Beekhuyzen M; van der Meer YG; de Gooijer A; Feith GW Ned Tijdschr Geneeskd; 2003 Feb; 147(7):307-10. PubMed ID: 12622009 [TBL] [Abstract][Full Text] [Related]
32. Statin safety: an appraisal from the adverse event reporting system. Davidson MH; Clark JA; Glass LM; Kanumalla A Am J Cardiol; 2006 Apr; 97(8A):32C-43C. PubMed ID: 16581327 [TBL] [Abstract][Full Text] [Related]
33. Adverse drug reaction reporting--2000: Part 2. Sutcliffe H; Macdonald L CMAJ; 2001 Jul; 165(1):83, 87. PubMed ID: 11468964 [No Abstract] [Full Text] [Related]
34. Summary of adverse event reports for veterinary biologic products received by the USDA from 1999 through 2005. Frana TS; Elsken LA; Karli SA J Am Vet Med Assoc; 2006 Oct; 229(7):1100-2. PubMed ID: 17014356 [No Abstract] [Full Text] [Related]
36. Adverse drug reactions and reporting. Witte R Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100 [No Abstract] [Full Text] [Related]
37. Vaccine adverse event reporting: the importance of follow-up. Varricchio F Expert Rev Vaccines; 2005 Aug; 4(4):445-8. PubMed ID: 16117700 [No Abstract] [Full Text] [Related]
38. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007. Johann-Liang R; Wyeth J; Chen M; Cope JU Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):24-7. PubMed ID: 19009550 [TBL] [Abstract][Full Text] [Related]
39. Reporting adverse vaccine events. O'Rourke K J Am Vet Med Assoc; 2003 Sep; 223(6):753-4. PubMed ID: 14507079 [No Abstract] [Full Text] [Related]
40. The state of dietary supplement adverse event reporting in the United States. Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]